Gene: VMA21
Official Full Name: vacuolar ATPase assembly factor VMA21provided by HGNC
Gene Summary: This gene encodes a chaperone for assembly of lysosomal vacuolar ATPase.[provided by RefSeq, Jul 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35851 | VMA21 Knockout cell line (HeLa) | Human | VMA21 | 1:3~1:6 | Negative | Online Inquiry |
KO35852 | VMA21 Knockout cell line (HCT 116) | Human | VMA21 | 1:2~1:4 | Negative | Online Inquiry |
KO35853 | VMA21 Knockout cell line (HEK293) | Human | VMA21 | 1:3~1:6 | Negative | Online Inquiry |
KO35854 | VMA21 Knockout cell line (A549) | Human | VMA21 | 1:3~1:4 | Negative | Online Inquiry |
VMA21 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the VMA21 gene, which encodes a critical component involved in the assembly of the vacuolar ATPase (V-ATPase) complex. This sophisticated biotechnology product allows researchers to investigate the gene's role within cellular processes such as pH regulation, ion homeostasis, and protein sorting. By creating a knockout model, scientists can elucidate the functional consequences of VMA21 loss on cellular physiology and deepen our understanding of related pathophysiological conditions.
The primary mechanism at work in these cell lines involves the disruption of V-ATPase activity, which is essential for ATP-driven proton transport across cellular membranes. Consequently, cells lacking VMA21 exhibit altered intracellular pH regulation and may provide insights into diseases such as cancer, where V-ATPase function is often dysregulated. These cell lines serve as invaluable tools in both fundamental biological research and therapeutic development, facilitating the exploration of novel drug targets aimed at modulating V-ATPase activity.
Compared to traditional wild-type cell lines, the VMA21 Gene Knockout Cell Lines provide clear advantages, including the ability to study specific gene functions in isolation and the potential to identify downstream signaling pathways affected by VMA21 loss. This tailored approach significantly enhances experimental precision and reduces confounding variables.
Offering these knockout cell lines positions your laboratory at the forefront of genetic research, creating opportunities for breakthrough discoveries that can lead to innovative treatment strategies. Our commitment to producing high-quality biological products is underscored by our team's extensive experience and dedication to advancing genetic research tools. With VMA21 Gene Knockout Cell Lines, researchers now possess a potent resource to unlock new avenues in the understanding of cellular and molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.